With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A trial by MSK researchers has shown that neoadjuvant treatment with GSK's Jemperli spared 80 percent of patients with dMMR ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Suzanne Vranica covers the advertising and marketing industries and is part of The Wall Street Journal’s media & marketing bureau in New York. During her long tenure on the beat, she’s covered the ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

UK dividends totalled £14 billion in the first quarter, falling 4.6% annually but still beating expectations. Which sectors ...

In subgroup analyses, increases in discontinuation of inhaled steroid therapy were greater among kids ages 5 years and ...

China has granted some exemptions on U.S. imports from its 125% tariffs and is asking businesses to identify goods that could ...

Dr. Ali Sherif normally gives about 50 doses of the measles vaccine to children each month at his clinic in Hobbs, New Mexico ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...